Stock Quote

AngioDynamics, Inc. (ANGO.O) (Nasdaq)
As of  3:37pm EST
15.91USD
Price Change
+0.19
Percent Change
+1.21%
 
$15.91
3:37pm EST
+1.21%
$15.72
$15.82
94,209
$16.20
$15.81
$16.00
$9.12
0.95
113,952

Research Another Stock: Symbol Look-up
Wall Street Breakfast: Must-Know News
Wednesday, 7 Oct 2009 07:19am EDT(Seeking Alpha) 
AngioDynamics F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
Tuesday, 6 Oct 2009 07:55pm EDT(Seeking Alpha) 
Equities Roundup: The Wizards of Oz
Tuesday, 6 Oct 2009 04:28pm EDT(Seeking Alpha) 
8 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
Wednesday, 26 Aug 2009 07:03am EDT(Seeking Alpha) 
AngioDynamics, Inc. F4Q09 (Qtr End 03/31/09) Earnings Call Transcript
Friday, 17 Jul 2009 12:43am EDT(Seeking Alpha) 
 
Name Current Position Compensation
Bucci, Vincent Chairman of the Board 15,914
Keltjens, Johannes President, Chief Executive Officer, Director 289,690
Gersuk, D. Joseph Chief Financial Officer, Executive Vice President, Treasurer 593,452

Profile

AngioDynamics, Inc. (AngioDynamics) is a provider of medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease (PVD) and local oncology therapy options for treating cancer, including radiofrequency ablation (RFA), systems, irreversible electroporation... Full Description

Company Address

AngioDynamics, Inc.
603 Queensbury Avenue
Queensbury   NY   12804
P: +1518.7981215
F: +1518.7981360

Analyst Research

Performance of Key Competitors

Company Price Change
Boston Scientific Corporation $8.17 +0.08
Johnson & Johnson $62.54 +0.23
C.R. Bard, Inc. $80.92 +0.20
  ANGO.O Industry
P/E(TTM) 38.73 3.76
P/S(TTM) 1.97 0.51
ROI(TTM) 2.63 2.54
ROE(TTM) 2.70 4.01
Consensus Recommendation Hold
EPS Est. (Current Period) 0.12
EPS Est. (Current Year) 0.51
Total Revenue $50.09M
Net Income $2.11M
EPS $0.09